These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 14983063)
1. Similarity between the C-terminal domain of the prion protein and chimpanzee cytomegalovirus glycoprotein UL9. Kuznetsov IB; Rackovsky S Protein Eng; 2003 Dec; 16(12):861-3. PubMed ID: 14983063 [TBL] [Abstract][Full Text] [Related]
3. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations. Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160 [TBL] [Abstract][Full Text] [Related]
4. beta-sheet constitution of prion proteins. Ji HF; Zhang HY Trends Biochem Sci; 2010 Mar; 35(3):129-34. PubMed ID: 20060302 [TBL] [Abstract][Full Text] [Related]
5. Evidence that the 127-164 region of prion proteins has two equi-energetic conformations with beta or alpha features. Derreumaux P Biophys J; 2001 Sep; 81(3):1657-65. PubMed ID: 11509378 [TBL] [Abstract][Full Text] [Related]
6. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides. Bertho G; Bouvier G; Hoa GH; Girault JP Peptides; 2008 Jul; 29(7):1073-84. PubMed ID: 18455265 [TBL] [Abstract][Full Text] [Related]
7. NMR solution structure and SRP54M predicted interaction of the N-terminal sequence (1-30) of the ovine Doppel protein. Pimenta J; Viegas A; Sardinha J; Martins IC; Cabrita EJ; Fontes CM; Prates JA; Pereira RM Peptides; 2013 Nov; 49():32-40. PubMed ID: 23973967 [TBL] [Abstract][Full Text] [Related]
8. Comparative computational analysis of prion proteins reveals two fragments with unusual structural properties and a pattern of increase in hydrophobicity associated with disease-promoting mutations. Kuznetsov IB; Rackovsky S Protein Sci; 2004 Dec; 13(12):3230-44. PubMed ID: 15557265 [TBL] [Abstract][Full Text] [Related]
9. Preventing misfolding of the prion protein by trimethylamine N-oxide. Bennion BJ; DeMarco ML; Daggett V Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389 [TBL] [Abstract][Full Text] [Related]
11. Effects of detergents on the secondary structures of prion protein peptides as studied by CD spectroscopy. Kuroda Y; Maeda Y; Sawa S; Shibata K; Miyamoto K; Nakagawa T J Pept Sci; 2003 Apr; 9(4):212-20. PubMed ID: 12725242 [TBL] [Abstract][Full Text] [Related]
12. Interactions of recombinant prions with compounds of therapeutical significance. Georgieva D; Schwark D; von Bergen M; Redecke L; Genov N; Betzel C Biochem Biophys Res Commun; 2006 Jun; 344(2):463-70. PubMed ID: 16630566 [TBL] [Abstract][Full Text] [Related]
13. Clustered negative charges on the lipid membrane surface induce beta-sheet formation of prion protein fragment 106-126. Miura T; Yoda M; Takaku N; Hirose T; Takeuchi H Biochemistry; 2007 Oct; 46(41):11589-97. PubMed ID: 17887730 [TBL] [Abstract][Full Text] [Related]
14. Spontaneous beta-helical fold in prion protein: the case of PrP(82-146). Saracino GA; Villa A; Moro G; Cosentino U; Salmona M Proteins; 2009 Jun; 75(4):964-76. PubMed ID: 19089953 [TBL] [Abstract][Full Text] [Related]
15. Water molecules as structural determinants among prions of low sequence identity. De Simone A; Dodson GG; Fraternali F; Zagari A FEBS Lett; 2006 May; 580(10):2488-94. PubMed ID: 16638576 [TBL] [Abstract][Full Text] [Related]
16. The structural transition of the prion protein into its pathogenic conformation is induced by unmasking hydrophobic sites. Leffers KW; Schell J; Jansen K; Lucassen R; Kaimann T; Nagel-Steger L; Tatzelt J; Riesner D J Mol Biol; 2004 Nov; 344(3):839-53. PubMed ID: 15533449 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a spontaneously aggregating amyloid-forming variant of human PrP((90-231)) through phage-display screening of variants randomized between residues 101 and 112. Verma A; Sharma S; Ganguly NK; Majumdar S; Guptasarma P; Luthra-Guptasarma M Int J Biochem Cell Biol; 2008; 40(4):663-76. PubMed ID: 18023239 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the proapoptotic intracellular mechanisms induced by a toxic conformer of the recombinant human prion protein fragment 90-231. Villa V; Corsaro A; Thellung S; Paludi D; Chiovitti K; Venezia V; Nizzari M; Russo C; Schettini G; Aceto A; Florio T Ann N Y Acad Sci; 2006 Dec; 1090():276-91. PubMed ID: 17384271 [TBL] [Abstract][Full Text] [Related]
19. Interaction of the 106-126 prion peptide with lipid membranes and potential implication for neurotoxicity. Dupiereux I; Zorzi W; Lins L; Brasseur R; Colson P; Heinen E; Elmoualij B Biochem Biophys Res Commun; 2005 Jun; 331(4):894-901. PubMed ID: 15882962 [TBL] [Abstract][Full Text] [Related]
20. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein. Leliveld SR; Stitz L; Korth C Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]